Article

Construction of a novel prognostic model for evaluation of immune infiltration and immunotherapy in lung adenocarcinoma

2023-03-31

Abstract excerpt

<h4>Background: </h4> Immunotherapy is an indispensable treatment in advanced lung adenocarcinoma (LUAD). However, only a small percentage of patients have experienced the specificity and effectiveness of immune checkpoint inhibitors. To maximize the therapeutic benefits for LUAD patients, a bioinformatics analysis was used to validate a prognostic signature for LUAD based on immune-related genes. <h4>Methods: </h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4e9f9ff7-48f2-56b2-8d60-2e479f8a3cc7
DOI: 10.21203/rs.3.rs-2701269/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Construction of a novel prognostic model for evaluation of immune infiltration and immunotherapy in lung adenocarcinomaDOI 10.21203/rs.3.rs-2701269/v1Read

A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma.Semantic proximity Read

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung AdenocarcinomaSemantic proximity Read

An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinomaSemantic proximity Read

Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of lung adenocarcinomaSemantic proximity Read

Identification of an immune-related genes signature in lung adenocarcinoma to predict survival and response to immune checkpoint inhibitorsSemantic proximity Read

Individualized Prognostic Score for Lung Adenocarcinoma Based on Immune StatusSemantic proximity Read

Identification and validation of immune-related lncRNA prognostic signature for lung cancerSemantic proximity Read

Identification of lung adenocarcinoma subtypes and a prognostic signature based on activity changes of the hallmark and immunologic gene setsSemantic proximity Read

Identification of prognostic candidate signatures by systematically revealing transcriptome characteristics in lung adenocarcinoma with differing tumor microenvironment immune phenotypes.Semantic proximity Read

An Immune Gene Signature for Prediction of Overall Survival and Response to Immune Checkpoint Inhibitors Therapy in Patients with Lung AdenocarcinomaSemantic proximity Read

Systematic construction and validation of an immune prognostic model for lung adenocarcinomaSemantic proximity Read

Establishing a prognostic model based on immune-related genes and identification of BIRC5 as a potential biomarker for lung adenocarcinoma patientsSemantic proximity Read